Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
AGL-2263,cas:638213-98-6
αE-[(2,3-dihydro-2-oxo-5-benzoxazolyl)methylene]-3,4-dihydroxy-β-oxo-benzenepropanenitrile
Product description
AGL 2263(C17H10N2O5,322.3) is an inhibitor of the insulin-like growth factor 1 receptor (IGF-1R; IC50 = 0.43μM).It also inhibits the insulin receptor (IR), protein kinase B (PKB), and Src in a cell-free assay (IC50s = 0.4,55, and 2.2μM respectively).
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| Purity | >90% |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 3 weeks |
| Stability | 1 year |
Document
msds of αE-(2,3-dihydro-2-oxo-5-benzoxazolyl)methylene-3,4-dihydroxy-β-oxo-benzenepropanenitrile Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
